Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT — Stella

Recruiting

Back to Glaucoma, Neovascular trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Thailand

Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University, Hat Yai, Changwat Songkhla

Key details

Sponsor

Prince of Songkla University

Enrollment target

~40 participants

Started

August 2018

Primary completion

July 2026

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov